The Path to Certainty: Diagnosis and Your Lab Results

The process of diagnosing an Inborn Error of Immunity (IEI) with autoinflammation is rarely a single event. Instead, it is a layering of evidence—starting with your symptoms and moving toward genetic and functional immune testing ^[1]. Because these conditions are rare and complex, your lab results often show a “seesaw” pattern: markers of high inflammation occurring alongside markers of a weak immune system ^[2][3].

The Initial Screening: Looking for the Clues

Your diagnostic journey usually begins with basic blood work to assess your overall immune “health” and levels of inflammation. Note that reference ranges and interpretation depend heavily on your age, sex, and treatment context.

• Complete Blood Count (CBC) with Differential: This test counts your white blood cells, red blood cells, and platelets. Doctors look for cytopenias (low cell counts), which are major clues in IEI, though non-specific ^[4]. In adults suspected of VEXAS, a high MCV (unusually large red blood cells) is a frequent early sign ^[5].
• Inflammatory Markers: Tests like CRP (C-reactive protein), ESR (Sedimentation Rate), and Ferritin measure systemic inflammation. High ferritin levels (sometimes exceeding 1,000 ng/mL) can be a warning sign of hyperinflammatory “storms,” but ferritin is non-specific, thresholds vary, and MAS/HLH cannot be diagnosed from this number alone ^[6][7].
• Quantitative Immunoglobulins (IgG, IgA, IgM): These measure the total number of antibodies in your blood. You may have low levels (hypogammaglobulinemia), which helps explain frequent infections. Results obtained during an acute infection, while on steroids, or while receiving IVIG may not represent baseline function ^[1][8].
• Vaccine Titers: This is a “functional” test checking if you have retained protection from past vaccines. A poor age-appropriate response suggests a deeper immunodeficiency ^[9][1].

Advanced Testing: Mapping the Immune System

If initial screens suggest an immune defect, specialists use more sophisticated tools to see exactly where the system is failing.

• Flow Cytometry (Lymphocyte Subsets): This technique uses lasers to count specific “flavors” of immune cells, such as B-cells, T-cells, and Natural Killer (NK) cells. Identifying which specific subset is missing helps narrow down the genetic cause ^[10][11].
• Functional Assays: These tests take your blood cells and “challenge” them in a lab dish to see how they react to germs or inflammatory triggers. For example, doctors may measure cytokine production or assess the oxidative burst ^[12][13].

Genetic Testing: A Crucial Diagnostic Tool

Identifying a specific mutation can help confirm your subtype.

• Targeted Gene Panels: These test a pre-selected group of genes known to cause autoinflammatory diseases (like TNFAIP3 for HA20). This is often the first genetic step ^[14].
• Whole Exome (WES) or Whole Genome Sequencing (WGS): If panels are negative, these broader tests look at all 20,000+ genes ^[15][16].

It is important to know that genetic testing is not always definitive proof. Some patients with genuine IEI have a negative panel because the gene is not yet known. Furthermore, finding a “Variant of Uncertain Significance” (VUS) does not establish a diagnosis—it must fit the clinical picture, and periodic reinterpretation may be useful.

Special Case: Diagnosing VEXAS Syndrome

Unlike most IEIs, VEXAS is not inherited; it is an “acquired” somatic mutation that appears later in life. Its diagnosis relies on a different pathway:

• Sensitive UBA1 Testing: The central diagnostic step is detecting a compatible somatic UBA1 variant in peripheral blood (or bone marrow). Because the mutation may only be in a small percentage of cells (mosaicism), highly sensitive tests are required ^[17][18].
• Bone Marrow Biopsy: While pathologists look for vacuoles (tiny bubble-like holes inside developing blood cells) as a hallmark of VEXAS, a bone marrow examination is generally indicated to evaluate unexplained cytopenias or suspected myelodysplastic syndrome (MDS). Vacuoles are supportive but neither universally required nor completely specific to VEXAS ^[19][20].

Completeness Checklist for Your Lab Reports

When reviewing your records, ensure you have seen or discussed these key items with your immunologist:

• [ ] CBC with Differential: Are there trends of low neutrophils, lymphocytes, or platelets, factoring in your current treatments?
• [ ] Immunoglobulin Levels: Are IgG, IgA, and IgM all within the age-appropriate range?
• [ ] Inflammatory Baseline: Do you know your “normal” CRP and Ferritin levels when you feel well?
• [ ] Genetic Variant Status: If a mutation was found, is it Pathogenic, Likely Pathogenic, or a VUS?
• [ ] Vaccine Response: Have you had “post-vaccination titers” drawn to see if your body built protection? ^[1][9]

Remember that in these conditions, trends matter more than single data points. A single “normal” lab result does not necessarily mean the disease is gone; it is the pattern over time that tells the true story of your immune health ^[21].